OSAM
GTHX

O'Shaughnessy Asset Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,347
Closed -$18K – 2604
2021
Q3 		$18K Hold
1,347
– – ﹤0.01% 1993
2021
Q2 		$30K Hold
1,347
– – ﹤0.01% 1736
2021
Q1 		$32K Buy
+1,347
New +$31.3K ﹤0.01% 1544
2020
Q1 		– Sell
-119
Closed -$3K – 1888
2019
Q4 		$3K Buy
+119
New +$2.78K ﹤0.01% 1613

Other funds holding GTHX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

O'Shaughnessy Asset Management's GTHX Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2021, closing a stake of 1,347 shares — an estimated $18K sold.

O'Shaughnessy Asset Management first reported a position in GTHX in Q4 2019 and held it in 4 quarters. The position peaked at $32K in Q1 2021. 108 funds tracked by Wall St. Rank hold GTHX as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 1,347 G1 Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $18K.
  • O'Shaughnessy Asset Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
  • O'Shaughnessy Asset Management's G1 Therapeutics, Inc. Common Stock position peaked at $32K in Q1 2021.
  • 108 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.